Physician profile
Laura E Vanpatten
NPI 1073748919
$4,989.20
in general payments reported to CMS, 2019-2025
32 companies · $1,567 in 2025
The $1,567 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $961 · 2023: $953 · 2024: $1,290 · 2025: $1,567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,621 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,621.35 |
| Education | $189.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $801.36 | 2021-2025 | Wakix |
| Astrazeneca Pharmaceuticals LP | $604.51 | 2021-2025 | Tezspire, Airsupra, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $456.78 | 2021-2025 | Ofev |
| Grifols USA, LLC | $382.87 | 2022-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $338.17 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $220.95 | 2022-2025 | Opsumit, Uptravi, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $219.53 | 2021-2025 | Dupixent |
| Mylan Specialty L.P. | $212.62 | 2022-2024 | Yupelri |
| Baxter Healthcare | $208.34 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Janssen Pharmaceuticals, INC | $189.38 | 2022-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $179.29 | 2024-2025 | Winrevair |
| Glaxosmithkline, LLC. | $119.58 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $110.11 | 2022-2025 | Glassia |
| United Therapeutics Corporation | $92.68 | 2021-2023 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $91.97 | 2021-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $86.41 | 2024-2025 | Sunosi |
| Inspire Medical Systems, INC. | $82.93 | 2023-2025 | Inspire |
| Viatris Specialty LLC | $73.62 | 2025 | Yupelri |
| Verona Pharma, INC. | $72.19 | 2025 | Ohtuvayre |
| Abbvie INC. | $54.86 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $50.22 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $49.41 | 2022-2024 | Acthar |
| Amgen INC. | $44.86 | 2022-2025 | Uplizna, Tezspire |
| Ani Pharmaceuticals, INC. | $42.46 | 2023 | Purified Cortrophin Gel |
| Insmed, INC. | $40.52 | 2024-2025 | Arikayce |
| Lilly USA, LLC | $34.88 | 2025 | Zepbound |
| Avadel Cns Pharmaceuticals, LLC | $33.75 | 2025 | Lumryz |
| Vifor Pharma, INC. | $24.04 | 2025 | Zemaira |
| Resmed Corp | $19.91 | 2024 | |
| Shionogi INC | $19.73 | 2023 | Fetroja |
| Advanced Respiratory, INC | $15.98 | 2021 | |
| Pfizer INC. | $15.29 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Vanpatten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.